Clinical and pharmacoeconomic aspects of omalizumab: a 4-year follow-up.
Menzella F, Facciolongo N, Piro R, Formisano D, Roggeri A, Simonazzi A, Castagnetti C, Carbonelli C, Zucchi L.
Menzella F, et al. Among authors: carbonelli c.
Ther Adv Respir Dis. 2012 Apr;6(2):87-95. doi: 10.1177/1753465811429478. Epub 2012 Feb 9.
Ther Adv Respir Dis. 2012.
PMID: 22323442
Free article.